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Mainz, West Germany
The effects of combined intravenous and intracoronary
streptokinase without (Group I, n = 103) or with (Group
II, n = 103) immediate coronary angioplasty were evalu-
ated during a long-term (3 year) follow-up of 06 patients
with acute transmural myocardial infarction. There were
no baseline differences between the groups with regard to
gender, age, infarct location, serum creatine kinase levels,
time between onset of symptoms and treatment and coro-
nary artery patency rate . Angioplasty was performed with
a success rate of 69% and a reocclusion rate of % .
Elective angioplasty was performed in ( 1%) of 103
patients in Group I and 9 (9%) of 103 patients in Group II,
with a success rate of 86% and 100%, respectively, re-
flecting the higher incidence of angina pectoris and an-
tianginal therapy in Group I . Coronary bypass surgery was
The intravenous administration of streptokinase in patients
with acute transmural myocardial infarction results in a
reperfusion rate of 45% (1-4) . Intracoronary administration
of streptokinase reopens 75% (5,6), recombinant tissue-type
plasminogen activator (rt PA) reopens 75% (7,8) and acy-
lated streptokinase reopens 75% of occluded vessels (9) . The
reperfusion rate can be increased to 90% by using angio-
plasty or reperfusion catheters (10,11) . Previous studies
(1 ,13) reveal that treatment with these agents achieves a
significant reduction in mortality in the early postmyocardial
infarction period . However, long-term follow-up has dem-
onstrated (13-16) that a greater percentage of such patients
have angina pectoris, a positive stress test or positive
thallium- 01 scintigrams or require percutaneous translumi-
From the Medical Clinic of the Johannes Gutenberg University, Mainz,
West Germany . This study was supported by Deutsche Lebensversicherungs-
Gesellschaft e .G ., Bonn, West Germany . It was presented in part at the 60th
Annual Scientific Session of the American Heart Association, Washington,
DC, November 1987 .
Manuscript received July 5, 1988 ; revised manuscript received February
, 1989, accepted March 15, 1989
.
Address for reprints : Raimund Erbel, MD, 11 . Medical Clinic, Johannes
Gutenberg University, Langenbeckstrasse 1, D-6500 Mainz,
West Germany .
©1989 by the American College of Cardiology
JACC Vol . 14, No .
August 1989
: 76-85
performed in 1 ( 0%) of 103 patients in Group I and 0
(19%) of 103 patients in Group II; there was one operative
death in each group .
During follow-up, coronary reocclusion or reinfarction,
or both, occurred in 5 ( 9%) of 87 patients in Group I and
in 16 (18%) of 87 patients in Group II with reperfused
vessels (p = NS)
. Heart failure occurred in 40% of the
patients in both groups who had increased end-diastolic and
end-systolic volumes. The survival rate after 3 years was
78% in Group I and 80% in Group II (p = NS) .
Thus, long-term follow-up of patients with acute trans-
mural infarction treated with and without immediate an-
gioplasty does not demonstrate any difference with regard
to clinical outcome and mortality .
(J Am Coll Cardiol 1989 ;14: 76-85)
nal coronary angioplasty or coronary bypass surgery subse-
quent to thrombolytic therapy than do patients in control
groups . Therefore coronary angioplasty was included in our
study as an additional form of therapy (17) . Several uncon-
trolled and nonrandomized studies (10,17,18) of such com-
bined therapy demonstrated an increased percent of reper-
fused vessels and a reduced reocclusion rate, but there are
conflicting results from other series (15,19, 0) .
The aim of this study was to analyze the long-term
follow-up of patients who, after thrombolytic therapy, were
randomly assigned to groups in which coronary angioplasty
was or was not performed .
Methods
Study patients . The study was performed from 1983 to
1985. The study group comprised 06 consecutive patients
who were admitted to the emergency ward of the Medical
Clinic of the University of Mainz within 6 h after the onset of
symptoms of acute myocardial infarction and who gave their
informed consent to the study . Diagnosis was based on 1)
acute chest pain lasting for >30 min, ) persistent ST
segment elevation of >0.3 mV in electrocardiographic
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(ECG) leads V, to V 6 or 0 . mV in leads I to III, aVL or
aVF. Exclusion criteria were 1) resuscitation, ) history of
allergic reaction to streptokinase, 3) previous cerebrovascu-
lar accident, 4) surgery in the preceding 10 days, 5) history of
acute peptic ulcer, and 6) history of bleeding problems .
Treatment regimen. All patients received intravenous
premedication including 5,000 U heparin, 50 mg pred-
nisolone, 3 mg/h nitroglycerin infused continuously for 4 h
and I g intravenously administered aspirin ; 50,000 U strep-
tokinase was infused intravenously within the 0 min before
cardiac catheterization .
According to the randomization table of Sachs ( 1),
patients were assigned in a random fashion to a group in
which coronary angiography was performed with use of
either a 7F catheter (Group I) or a 9F guide catheter (Group
II) . In all patients, the left coronary artery was visualized
first . After opacification of the infarct-related vessel, intra-
coronary streptokinase infusion was initiated by a 50,000 U
bolus and continued at a rate of 4,000 U/min until a total dose
of 00,000 U was reached (15) .
During intracoronary streptokinase administration, a 3F
Gruntzig coronary infusion catheter (recanalization catheter
type CI, Schneider Medintag) for Group I or a 4F Gruntzig
balloon catheter (Schneider Medintag) for Group II was
prepared . If the vessel was occluded, the catheter was
introduced and a flexible guide wire was advanced through
the thrombus for mechanical recanalization and then with-
drawn to permit anterograde flow . Balloon inflation in Group
II was avoided at this time . During this period, streptokinase
administration had to be interrupted for to 4 min . Imme-
diately after this procedure, streptokinase was administered
superselectively through a 3F or 4F catheter . Coronary
angioplasty of the infarct-related vessel was then attempted
in all but two patients in Group 11 . Patients with difficult
coronary anatomy were not excluded . For angioplasty 3 .7
mm balloon-tipped catheters with steerable wires were used,
in 1983 and 1984 J and G 0- 0 or 0-30 Gruntzig catheters
with fixed wires were used . Balloon size was chosen accord-
ing to the location of the lesion and the coronary vessel size .
The aim was to reduce coronary luminal narrowing by >_ 0%
and to avoid reocclusion or emergency bypass surgery, if
possible .
Biplane left ventricular angiography was performed using
a pigtail catheter to inject 40 ml Urografin 70% (Byk Gulden)
at 14 ml/s . The X-ray equipment was a Siemens biplane
Pandoros Optimatic Unit incorporating a variable mode
image intensifier .
Anticoagulation . Heparin therapy was started within 5 to
6 h after lysis, when the initially increased thrombin time
started to decrease (15) . Overlapping phenprocoumon ther-
apy, which was maintained for 6 months, was interrupted for
the predischarge and 6 month control studies . Thereafter
therapy was chosen on an individual basis .
Follow-up control catheterization studies. Right and left
heart catheterization with coronary arteriography was re-
peated at hospital discharge in Group I in 69 (79%) of 87 and
in Group II in 69 (76%) of 91 surviving patients and after 6
months in Group I in 41 (48%) of 85 and in Group II in 41
(48%) of 86 surviving patients (Fig . I to 3) . Left cineventric-
ulography was performed during atrial pacing, at a rate
corresponding to that of the initial cineventriculogram done
during the acute stage of infarction, to exclude rate-related
effects on left ventricular function (15) .
Cineventriculograms made during the acute stage could
be analyzed in 85 (83%) of the 103 patients in each group . In
the remaining patients either the film quality was poor or
multiple extrasystoles were present . Of these 85 patients in
each of Groups I and II, 13 and 1 patients refused predis-
charge catheterization, 3 and 4 underwent aortocoronary
bypass surgery and 69 and 69 in Groups I and II, respec-
tively, consented and underwent elective repeat predis-
charge cardiac catheterization . Of the 83 and 85 patients still
alive at the 6 month control stage, 34 and 35, respectively,
refused repeat catheterization and 8 and 7 patients had
already undergone aortocoronary bypass surgery ; thus, 41
and 43 patients of each group underwent 6 month follow-up
cardiac catheterization . There was no patient selection be-
cause all patients had been asked to undergo repeat study .
No differences were found between those who underwent
such control study and those who did not with respect to
age, gender, infarct location, two or three vessel coronary
disease, impairment of left ventricular function in the 4th
week, clinical signs of cardiac failure and angina pectoris .
Measurements and calculations . Left ventricular volumes
were determined with use of a biplane disk method, as
described previously (15), with a semiautomatic computer
system (Kontron 00). End-diastole was measured at the
peak of the R wave with use of frame signal recorded
simultaneously with the ECG during cineventriculography at
a paper speed of 50 mm/s. End-systole was defined as the
smallest ventricular silhouette . Stroke volume and ejection
fraction were calculated . All volume measurements were
corrected for body surface area and expressed as indexes .
Cineventriculograms in the right anterior oblique projec-
tion were analyzed for regional wall motion, with use of a
fixed system with the diastolic center of gravity as the center
point creating 3 radii . The percent shortening of the 3
segments was calculated and normal values were established
in 30 control subjects as described previously (15) .
Reperfusion of coronary arteries was defined as total
reopacification of the distal part of the vessel, even with
delayed washout (Thrombolysis in Myocardial Infarction
[TIMI] grades and 3) .
Two experienced angiographers evaluated the severity of
residual stenosis for all patients in Groups I and 11 . The
coronary angiograms were projected and magnified and
calipers were used to measure the stenoses . At least two
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projections for the right and three for the left coronary artery
were reviewed, including left anterior oblique caudal-cranial
projections in all patients. The stenosis values were aver-
aged. Successful coronary angioplasty was defined as a
decrease in coronary luminal narrowing of >_ 0% . Resteno-
sis was defined as redevelopment of stenosis to >_70% or
alternatively to ?50% together with a 50% loss of initial gain
from coronary angioplasty .
Follow-up . Follow-up of patients at 1 , 4 and 36 months
was carried out in the outpatient clinic ; it consisted of a
physical examination, routine laboratory tests, ECG and
exercise ECG and chest radiograph . Patients who were not
seen were contacted by mail or telephone, to ascertain
whether interim coronary artery balloon angioplasty or
bypass grafting had been performed . No information was
received during follow-up for 6% of the patients after 1
months, for 7% after 4 months and for 7% after 36 months .
Statistics . All results are given as mean values ± SD .
Statistical analyses were performed by using variance anal-
ysis to determine the difference between the means in the
two groups and by chi-square analysis to determine the
difference in proportions between the groups . A probability
of <0.05 was regarded as significant . Kaplan-Meier survival
curves were calculated .
Results
Clinical data . Analysis of the clinical data from the
short-term stage revealed no significant differences between
Group I (n = 103) and Group II (n = 103) with regard to age,
gender, infarct location and peak serum creatine kinase
levels . The time delay between the onset of symptoms and
treatment and reperfusion was the same in both groups
(Table 1) .
After 3 years, evaluation according to the New York
Heart Association classification revealed similar results for
both groups (Table ). Drug treatment is given for both
groups in Table 3
. Of 80 patients in Group I and 8 patients
in Group II, 50 (63%) and 43 (5 %), respectively, had
followed a rehabilitation program after 3 years and 19 ( 4%)
and 17 ( 1%) did not return to work after discharge from
hospital .
Coronary anatomy . After initiation of thrombolytic treat-
ment in the emergency ward combined with intracoronary
application of streptokinase and mechanical recanalization
in occluded vessels, an open infarct-related coronary artery
was found in 87 (84%) of the 103 patients in Group I and 87
(84%) of the 103 patients in Group II .
In Group 1,
residual luminal narrowing of the infarct-
related vessel measured 94 -}
19% after initiation of throm-
bolytic therapy intravenously
. After intracoronary infusion
of streptokinase and mechanical recanalization it decreased
to 78 ± 19% (p < 0.01) in Group I and 78 ± 15% (p < 0
.01)
in Group II . Predischarge and 6 month follow-up studies
Table 1. Clinical Features of Groups I and II
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Awl = anterior wall infarction ; CK = peak serum creatine kinase level
;
F = female
; Group I and Group 11 = patients with thrombolytic therapy
without and with immediate angioplasty, respectively
: IWI = inferior wall
infarction : M = male .
revealed a value of 7 ±
3% and 64 ± 40%, respectively, in
Group I (Fig . 1)
. These values were not significantly different
from those after intervention .
In Group II, coronary luminal narrowing was reduced
significantly (p < 0 .01) with successful angioplasty to 9 ±
18%. There was no significant change during hospital stay
(Fig . ) . Predischarge coronary stenosis measured 30 ±
4%;
the 6 month follow-up study revealed a significant increase
to 46 ± 39% . In patients with unsuccessful angioplasty in
Group II, coronary stenosis remained nearly unchanged, 78
±
% at predischarge and 90 ± 17% at 6 months follow-up
study (Fig. 3) .
Coronary angioplasty . Angioplasty was immediately per-
formed in 85 of the 87 patients in Group II
; it was not
possible in patients for technical reasons
. Angioplasty was
successful in 59 (69%) of the 85 patients, with a
0%
Table
. New York Heart Association (NYHA) Classification of
Group I and II After 3 Years
Group I
(n = 103)
Group 11
(n = 103)
Mean age (yr) 56 ± 11 56 ± 10
Patients >70 years (n) 13 13
Gender (M/F) 86/17 88/15
Infarct location
Awl 56 44
IWI 47 57
AWI/IWI -
One vessel disease 44 48
Two vessel disease 37 33
Three vessel disease
Peak CK (U/liters)
1,188 ± 884
1,30
± 895
Cardiogenic shock 6 14
Death due to cardiogenic shock 4 of 6 5 of 14
Time from onset of symptoms until 151 ± 69 144 ± 6
admission (min)
Infarct time (min)
17 ± 78 18 ± 74
Coronary bypass surgery 1 0
During initial hospital stay 7 4
Because of ischemia 3 1
Because of multivessel 4 3
and mainstem disease
NYHA
Class Group I (n = 80)
Group 11 (n = 8 )
I ( 7%)
0( 5%)
II
7 (34%)
9(35%)
III
0(
5%)
3 ( 8%)
IV
11 (14%) 10(1 %)
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Table 3. Drug Treatment 3 Years After Thrombolytic Therapy for
Acute Transmural Myocardial Infarction Without (Group I) and
With (Group II) Immediate Angioplasty
m
reduction in coronary luminal narrowing considered to be
significant . In ( %) of the 85 patients in whom thrombolytic
therapy had already achieved reperfusion, coronary vessel
reocclusion occurred during angioplasty .
During follow-up coronary angioplasty was performed in
( 1%) of 103 patients in Group I because of angina
pectoris and a positive exercise stress test . In three of these
patients it was performed 11, 1 and 15 days, respectively,
after acute myocardial infarction . The other 19 patients
underwent angioplasty after hospital discharge ; the success
rate was 86% . In 9 (9%) of 103 patients in Group II, repeat
angioplasty was performed, with a success rate of 100%, on
an elective basis after 3 months in 1 patient and later in the
other 8 patients because of recurrent angina pectoris and a
positive exercise stress test .
Figure 1 . Coronary luminal narrowing in Group I (n = 103) after
intravenous streptokinase (IV SK), before and after intracoronary
infusion of streptokinase (IC SK), after attempted mechanical
recanalization (MECH RE) of the occluded vessel as well as at the
predischarge (PRE) and 6 month follow-up .
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Figure . Coronary luminal narrowing in Group II after intravenous
administration of streptokinase (IV SK), before and after intracor-
onary administration of streptokinase (IC SK), after attempted
mechanical recanalization (MECH RE) of the occluded vessel
before and after angioplasty (Dilatation) as well as at the predis-
charge (PRE) and 6 month follow-up, including only the 57 patients
in whom angioplasty was successful .
In the patients in Group I and in the 9 in Group 11 who
underwent elective coronary angioplasty, angina pectoris
improved in 16 (7 %) Group I and 4 (45%) Group II patients ;
it remained unchanged in 4 (18%) Group I and 4 (45%) Group
II patients and it worsened in (9%) Group I and 1 (11%)
Group II patients. Repeat coronary angioplasty was neces-
sary in 5 ( 3%) Group I and 3 (33%) Group II patients .
Coronary bypass surgery . This procedure was performed
in 1 ( 0%) of the 103 patients in Group I and 0 (19%) of the
103 patients in Group because of multivessel or main stem
stenosis, with a perioperative mortality in I patient in each
group. It was performed during the initial hospital stay in 7 of
the 1 patients in Group I and in 4 of the 0 patients in Group
II . Late death after bypass surgery occurred in two patients
in Group I (after 9 and 365 days, respectively) and in I
patient in Group 11 (after years) .
Reocclusion . The clinical data of patients with reocclu-
sion or reinfarction, or both, of the infarct-related artery, ( 5
[ 9%] of 87 patients in Group I and 16 [18%] of 87 patients in
Group II) documented by clinical catheterization or autopsy
data are listed in Table 4 . The differences between the two
groups were not significant during hospital stay or during
follow-up, with a trend to a lower reocclusion rate in Group
11. Reocclusion or reinfarction, or both, occurred during the
hospital phase in 17 (68%) of 5 patients in Group I and in 13
Group I
(n = 80)
Group 11
(n = 8 )
No drug
6(8%) 901%)
Nitrates
34 (43%) 8 (31%)
Calcium channel blockers 45 (56%) 41 (50%)
Beta-blockers 14 (18%) 901%)
Cardiac glycosides 0 ( 5%)
13 (16%)
Diuretics 16( 0%) 16( 0%)
Antiarrhythmic agents
4 (5%) 5 (6%)
80
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Figure 3. Coronary luminal narrowing in Group II after intravenous
administration of streptokinase, before and after intracoronary
administration of streptokinase, after attempted mechanical recanal-
ization in the occluded vessel before and after angioplasty as well as
at the predischarge and 6 month follow-up study, including only the
44 patients in whom angioplasty was unsuccessful (decrease in
luminal narrowing < 0%) .
(81%) of 16 patients in Group II . In Group I, reocclusion or
reinfarction, or both, of the infarct-related vessel, open at
the first opacification occurred in 6 (16%) of 37 patients ; in
vessels reopened by intracoronary application of streptoki-
nase, reocclusion occurred in 4 ( 4%) of 17 patients ; after
mechanical recanalization it occurred in 15 (45%) of 33
patients .
Ventricular function . A significant increase in end-
diastolic volume index was observed only in Group I and not
in Group II patients (Table 5) . During the hospital stay >30%
of the patients in both groups demonstrated an increase in
end-diastolic volume index of > 0% and in end-systolic
volume of >40% . After hospital discharge, 0 ( 8%) in
Group I, and 31 (44%) in Group II showed further increases
in end-diastolic and end-systolic volumes (Fig . 4, Table 6) .
Regional wall motion (Fig . 5). A significant improvement
in regional wall motion during follow-up was found in Group
II patients with anterior myocardial infarction, but not in
Group I patients, who showed only a slight improvement
during follow-up . In Group I and II patients with inferior
myocardial infarction, a reduction in the shortening fraction
of segments of the contralateral wall was observed, but not
of segments of the inferior wall during follow-up .
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Table 4. Clinical Data of 40 Patients With Reinfarction or
Reocclusion or Both
Angio = angiographic study
; ECG = electrocardiogram ; IC SK =
intracoronary administration of streptokinase ; LAD = left anterior descend-
ing coronary artery
; LCx = left circumflex coronary artery ; RCA = right
coronary artery ; S and U = successful and unsuccessful angioplasty, respec-
tively .
Mortality (Fig. 6) . After 3 years, 78% of patients in
Group I and 80% of those in Group II were still alive (p =
NS). The causes of death are given in Table 7 .
Discussion
Thrombolysis plus angioplasty versus thrombolysis alone .
There were no significant differences in clinical status during
follow-up in patients who underwent angioplasty immedi-
ately after combined intravenous and intracoronary throm-
bolytic therapy and in those in a control group who under-
went thrombolytic therapy without angioplasty . However,
patients who did not undergo immediate angioplasty re-
ceived more nitrates and beta-blockers, possibly because of
a higher frequency of persistent or recurrent ischemia . This
possibility is supported by the higher rate of elective coro-
nary angioplasty in this group . Other studies (1 ,13, , 3)
reported that a similar percent of patients (up to 40%)
suffered from angina pectoris after thrombolytic as after
placebo therapy .
Group I Group II
Total (n) 5 16
8U
8S
Reinfarction 18
14
Proved by
Clinical, ECG, enzymes 9 6
Coronary angiography 8 7
Autopsy 8 3
Infarct related vessel
LAD 13 7
LCx -
RCA 10 9
Early/late reocclusion
:5
4h / > 4h to 4th day 4/6 6/4
>_ 5th day 15 6
ECG signs of recurrent 9 14
myocardial ischemia 7 U
7S
Coronary thrombus
Initially 9
Persistent 6 -
Coronary stenosis (%) 76
±
3 58 ± 34
86 ± 16 U
6 ± 1 S
Vessels
Open at the 1st angiography 6/37 1/
Reopened during IC SK 4/17 8/ 7
Recanalized mechanically 15/33 7/37
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Clinical data . Cardiac glycosides and diuretics were ad-
ministered more often in patients who had not undergone
coronary angioplasty than in patients who had, possibly
owing to a higher incidence of heart failure in the former .
Other authors ( 4- 6) have reported a rate of heart failure
after thrombolytic therapy ranging from 0 to 6% to 0%. In
controlled trials ( , 7) the incidence of heart failure in
patients receiving no thrombolytic therapy was higher than
in those with thrombolytic therapy, but in the large GISSI
study this was found neither for the hospital stay nor for the
1 month follow-up period, the incidence rate being 13% and
15%, respectively (1 , 8). Similar results have been reported
in controlled studies ( 9) and pooled data analysis (30) .
These results may be due to the late initiation of throm-
bolytic therapy and the inclusion of patients with onset of
infarction >_6 h before therapy (13, 8) .
Restenosis . The degree of residual luminal narrowing of
the infarct-related artery after thrombolytic therapy and
successful coronary angioplasty at the 6 month follow-up in
our study was similar to that reported by others, ranging
from 3% to 43% (8,11,15,18, 4) . Residual luminal narrow-
ing after angioplasty of >30%, however, is related to a high
restenosis rate (31) . During follow-up, the restenosis rate
ERBEL ET AL .
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Table 5
. End-Diastolic and End-Systolic Volume Indexes, Stroke Volume Index and Ejection Fraction in Group I and II in the Acute
Stage, Before Discharge and After 6 Months
Limits of normal values : EDVI <75
MI/M
: EF >55%: ESVI < 5 ml/m ; SVI <40
MI/M .
*p < 0 .05 . A = acute study ; B = predischarge control ; C = 6 month
control : EDVI = end-diastolic volume index ; EF = ejection fraction : ESVI = end-systolic volume index ; n = number of patients ; SVI = stroke volume index ;
WI = wall infarction.
after thrombolytic therapy and successful angioplasty was
38% . The restenosis rate is thus higher than that reported for
elective coronary angioplasty, which ranges from 0% to
30% (3 ) . On the other hand, the restenosis rate seems to be
similar to that in patients with unstable angina and recanal-
ization of occluded coronary vessels (3
,33). In both coro-
nary events, superposition of thrombus formation is present
in addition to plaque formation, suggesting that there are
intrinsically different vascular and hematologic properties or
a more pronounced tendency toward pathologic rupture of
the vessel wall as a result of longitudinal shearing and
intraplaque bleeding in these coronary events (33,34) . Rates
of repeat angioplasty in our two patient treatment groups
correspond to those of other reports ( 4,35) .
Limitations on the interpretation of the results are related
to incomplete follow-up but repeat cardiac catheterization of
surviving patients, with open coronary arteries, after imme-
diate coronary angioplasty was performed in 59 (79%) of 75
patients before discharge and 37 (5 %) of 71 patients after 6
months. For cardiac catheterization, as for all invasive
procedures, only a limited number of patients can be restud-
ied for follow-up analyses (33,35) . In our study, patients had
to give written informed consent for three catheterizations .
EDVI
(M I/M )
ESVI
(M I/M )
C
SVI
(MI/M )
C
EF (%)
A B C
A B A B A B
C
Group I
Mean 86 98* 107 39 45 50 48
53
56 55
56 55
±SD 3 9
33 15 5 30 15 14 15 10 13 15
n
85 69 40
Anterior WI
Mean 89 101 113 4 47 57
47 53 56 53 55 53
±SD
1 36 39 14 30 37 13 16 14
9 14 16
n 45 37
Inferior WI
Mean
84
95 98
35 4 4 49 53 57 58 57 58
±SD 6 19 15 16 17
16 10 16 10 11 18
n
40 3 18
Group II
Mean 9 98 106 43 47 51 50 53 55 55 54
55
±SD
1 7 33 17 1 3 14 16 17 1 14
1
5
n 85 69 41
Anterior WI
Mean 96
105 116 50 49 59 46 56* 57 49 54 53
±SD 0 4 4
18
4 43 1
0 16 1 17 17
n 35 8 15
Inferior WI
Mean 91 94 101 37 45 46 53 51 55 59 55 56
±SD 8 5 13 19 1 5 14 17 10 1 14
n 50 41 6
8A
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acute
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Figure 4 . Percent increase of end-diastolic volume index (A) and
end-systolic volume index (B) in Group I (streptokinase + mechan-
ical revascularization) and Group II (streptokinase + angioplasty)
comparing the acute and predischarge data as well as the predis-
charge and 6 month follow-up studies . Changes of more than ± 0%
(shaded area) were regarded as significant .
Therefore, some patients refused a third restudy . In addi-
tion, patients were not reexamined because of performance
of bypass surgery and death . This is a limitation of our study .
But the results in the restudied patients are helpful in
interpreting the clinical follow-up data of the study group as
a whole .
Measurement of coronary stenosis is more precise than
estimation of coronary luminal narrowing with use of hand-
held calipers. We were interested in determining the reste-
nosis rate during follow-up, not the absolutely correct lumi-
nal narrowing . As there are only a few cases in which
luminal narrowing is near the 70% threshold, our evaluation
seems to be correct . Other investigators (36,37) have indi-
cated that only changes > 10% should be considered signif-
icant .
Reocclusion . Follow-up demonstrated that reocclusion
and reinfarction occurred mainly during the hospital stay .
Subsequent cardiac events were rare. Successful angio-
plasty, not the intention to perform angioplasty, reduces
reocclusion rates, as previously pointed out (15) . Assign-
-380
acute predischarge acute predischarge
vs . VS .
Vs. Vs.
predischarge 6 months predischarge 6 months
GROUP I GROUP II
•
•
t
•
I
ment to immediate angioplasty does not change reocclusion
rates in unselected patients (15) .
Reocclusion occurred in about 15% of the patients whose
infarct vessel had already been reopened by intravenous
streptokinase ; this rate is comparable with that reported in
other studies using streptokinase . Reocclusion rates rose to
45% in patients with a mechanically reperfused infarct
vessel; this increase may be due to more extensive thrombus
formation or a more pronounced pathologic rupture of the
vessel wall as a result of the longitudinal shearing of the
arteriosclerotic and fibrocellular material (33), which could
be only slightly reduced by additional angioplasty . Not all
reocclusions led to reinfarction, as others (15) have noted .
The relation of the reinfarction rate to the reocclusion rate
was comparable with that reported by O'Neill et al . (19) .
Ventricular function . During follow-up, end-diastolic and
end-systolic volumes increased in both treatment groups,
but this increase was more pronounced in patients with
anterior than in those with inferior infarction . In the follow-
up study of Jeremy et al . (38), three times as many patients
showed an increase as showed a decrease in end-diastolic
volume, a finding similar to our finding that end-diastolic and
end-systolic volumes increased in about 40% and decreased
in only 15% of patients . This increase in volume may explain
the high percentage of patients with heart failure after
thrombolytic therapy .
Other studies also showed a lower ejection fraction in
patients who underwent immediate angioplasty after throm-
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Figure 5 . Regional wall motion in patients with anterior wall
infarction (AW) in Group I (A) and Group 11 (B) with shortening
fraction (SF) of 3 radii (mean values) in the acute, predischarge
(predis), and 6 month follow-up (control) cineventriculograms .
Normal range is illustrated as a shaded area . *Indicates p < 0 .05 .
PW = posterior wall .
bolytic therapy than in patients who did not (8,19,35,39) .
During follow-up, our two treatment groups became compa-
rable with respect to ejection fraction, indicating that the
ejection fraction values increased more in the angioplasty
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Figure 6 . Three year survival curves for Group I (streptokinase +
mechanical revascularization) and Group II (streptokinase + angio-
plasty [PTCA]) .
than in the other group and were equivalent at predischarge
examination . A possible explanation for this unexpected
result may be the rapid and unlimited flow to the infarct zone
after the occluded vessel is opened, enhancing possible
reperfusion injury, as discussed by many investigators (40)
but not yet proved. Another explanation may be the in-
creased volume of contrast material used in angioplasty . A
third explanation may be that coronary angioplasty might
displace thrombus to small vessels and that the thrombi
might dissolve after some time . The possibility of reperfu-
sion damage and the possibly higher risk associated with
immediate angioplasty (8) have currently led to angioplasty
being postponed and performed on a more elective basis .
Regional wall motion . In patients with anterior myocar-
dial infarction, wall motion improved during the hospital
stay, as previously reported for patients receiving combined
thrombolysis and angioplasty (15,35) . During follow-up, a
further improvement in wall motion was observed, suggest-
ing a delayed recovery of ischemic myocardium after reper-
fusion . Despite a 0% rate of delayed angioplasty in patients
who had not undergone immediate angioplasty, no signifi-
cant wall motion improvement could be detected in this
*n = 66 for Group I and 68 for Group 11 : to = 36 for Groups I and II
. Number and percent of patients demonstrating an increase (T) or decrease ( .( )
(-> or <-
0%) or no change (=) (? and <_ 0%) . Abbreviations as in Table 5 .
Group I
Group 11
EDVI
ESVI EDVI ESVI
Acute
versus
(T) 6(39%) 9 (44%) (3 %) 8 (41%)
Predischarge* (_) 8 (1 %)
15 ( 3%) 14 ( 1%) 19( 0%)
( [ ) 3 (49%) (33%) 3 (47%) 1 (31%)
Predischarge
versus
(T ) 7 ( 0%) 10( 8%) 11 (31%) 16(44%)
6 month controlt
(_)
6(7 %) 16(44%)
1 (58%) 10( 8%)
( ) 3 (8%) 10 ( 8%) 4(11%) 10( 8%)
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Table 7. Mortality in Groups I and II by Cause of Death, With Number of Days After Myocardial Infarction
Figures in parentheses indicate number of patients .
group. Suryapranata et al . (35) demonstrated improved wall
motion in both inferior and anterior infarction . This differ-
ence may be related to the different study design or different
wall motion analysis algorithm .
Mortality . Long-term results demonstrated no significant
difference in outcome between patients treated with and
without coronary angioplasty in addition to thrombolytic
therapy with an achieved patency rate of 84%
. Comparable
long-term results in randomized trials are not yet available .
The 80% 3 year survival rate of our patients treated with
angioplasty corresponds to the survival rate reported re-
cently by Stack et al . (
) for patients treated with throm-
bolytic therapy and angioplasty .
Clinical implications . Our results show that the immedi-
ate performance of coronary angioplasty as a supplement to
thrombolytic therapy in an unselected group of patients does
not lead to a significant reduction in morbidity and mortality
compared with that in a group of patients with combined
thrombolytic therapy and mechanical recanalization (by a
flexible guide wire) . If, however, suitable patients are spe-
cially selected and if improved angioplasty techniques with a
higher rate of success are used, we believe that angioplasty
will improve the results of thrombolysis
.
We thank M
. Grin, MD, of St . Vincenz Hospital ; P. Baum, MD, of
Hildegardis Hospital ; Abel, MD, St . Josef Hospital : H. von Egidy, MD .
Dr .-Horst-Schmidtkliniken of Hospital Wiesbaden ; and H . J
. von Mengden,
MD, Hospital Russelsheim for their cooperation . We also thank Margot
Meurer for her help with illustration and Helga Pahlen, Andrea Muller
.
Martina Haidasch, and Angela Herbrik for assistance in preparing the
manuscript .
JACC Vol . 14, No .
August 1989
: 76-85
References
I . Rogers WJ, Mantle JA . Hood WP, et al . Prospective randomized trial of
intravenous and intracoronary streptokinase in acute myocardial infarc-
tion . Circulation 1983 ;68 :1051-61 .
. Stack RS, O'Connor CM, Mark DB, et al . Coronary perfusion during
acute myocardial infarction with a combined therapy of coronary angio-
plasty and high-dose intravenous streptokinase
. Circulation 1988
:
77 :151-61 .
3 . TIMI Study group . The thrombolysis in myocardial infarction (TIMI)
trial : phase I findings . N Engl J Med 1985 ;31 :93 -6.
4 . Schroder R, Biamino G, von Leitner ER, et al . Systemische Thrombolyse
mit Streptokinase-Kurzzeitinfusion bei akutem Myokardinfarkt . Z Kar-
diol 198 ;71 :709-18 .
5 . Rentrop P. Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K .
Selective intracoronary thrombolysis in acute myocardial infarction and
unstable angina pectoris . Circulation 1981 :63 :307-17 .
6. Kennedy JW . Ritchie JL . Davis KB, Fritz JK . Western Washington
randomized trial of intracoronary streptokinase in acute myocardial
infarction . N Engl J Med 1983 :309 :1477-8 .
7
. Passamani E, Hodges M, Herman M, et al . The thrombolysis in myocar-
dial infarction (TIMI) phase II pilot study : tissue plasminogen activator
followed by percutaneous transluminal coronary angioplasty
. J Am Coll
Cardiol 1987 :10 :51B-64B .
8
. Topol EJ, Califf RM, George BS, et al . A randomized trial of immediate
versus delayed elective angioplasty after intravenous tissue plasminogen
activator in acute myocardial infarction . N Engl J Med 1987 ;317 :581-8 .
9 . Kasper W, Meinertz T . Wollschlager H, et al
. Coronary thrombolysis
during acute myocardial infarction by intravenous BRL 69 1, a new
anisoylated plasminogen-streptokinase activator complex
. Am J Cardiol
1986 :58 :418- 1 .
10 . Hartzler GO, Rutherford BD, McConahay DR. Percutaneous translumi-
nal coronary angioplasty : application for acute myocardial infarction . Am
J Cardiol 1984 :53 :117C- 1C .
11 . Erbel R, Pop T, Meinertz T, et al . Combined medical and mechanical
recanalization in acute myocardial infarction
. Cathet Cardiovasc Diagn
1985 :11 :361-77
.
Group I (n = 103) Group 11 (n = 103)
Cause of Death
Days After
Admission Cause of Death
Days After
Admission
Cardiac
Reinfarction (9)
. 3 . 4, 7, 8, 17,
Cardiac
Reinfarction (4) , 3, 463, 8 1
17
. 47, 608
Cardiac rupture (
)
, Cardiac rupture ( ) 5, 14
Asystole (1) I Cardiogenic shock (4) 1, 1, 1 . 1
Sudden death (3) 13, 9 , 365 Sudden death (3) 56, 90 . 516
Cardiogenic shock (4) I . 1, 09, 544 Postoperative cardiogenic shock 144
Postoperative cardiogenic shock (I) 7 Postoperative septic shock (I)
53
Noncardiac
Pneumonia (1)
Noncardiac
Shock lung (3) 7, 9, 13
Cerebral bleeding (1) 7 Cerebral bleeding (1) 1
Prostate carcinoma (1) 1 .103 Stomach carcinoma (1) 341
Cerebrovascular accident (I) 51
0 of 103 patients had cardiac cause of death (18%)
3 of 103 patients had noncardiac cause of death (3%)
15 of 103 patients had cardiac cause of death (15%)
6 of 103 patients had noncardiac cause of death (6%)
JACC Vol
. 14, No .
	
ERBEL ET AL .
August 1989: 76-85 LONG-TERM RESULTS OF THROMBOLYSIS AND ANGIOPLASTY
1 . Gruppo Italiano per to Studio della Streptochinasi nell'lnfaro Miocardico
(GISSI) . Effectiveness of intravenous thrombolytic treatment in acute
myocardial infarction . Lancet 1986 ;1 :397-40 .
13 . Simoons ML, Serruys P, van den Brand M, De Zwaan C, et al . Improved
survival after early thrombolysis in acute myocardial infarction . Lancet
1985 ; :578-81 .
14 . Fung AY, Lai P, Topol EJ, et al . Value of percutaneous transluminal
coronary angioplasty after unsuccessful intravenous streptokinase ther-
apy in acute myocardial infarction . Am J Cardiol 1986 :58 :686-91 .
15 . Erbel R, Pop T, Henrichs KJ, et al . Percutaneous transluminal coronary
angioplasty after thrombolytic therapy : a prospective controlled random-
ized trial . J Am Coll Cardiol 1986 ;8 :485-95
.
16 . von Essen R, Uebis R, Schmidt W, et al . Intrakoronare Streptokinase
beim akuten Herzinfarkt . Dtsch Med Wochenschr 1985 ;110 :570-5 .
17 . Meyer J, Merx W, Schmitz H, et al . Percutaneous transluminal coronary
angioplasty immediately after intracoronary streptolysis of transmural
myocardial infarction . Circulation 198 ;66 :905-13 .
18 . Serruys PW, Wijns W, Van den Brand M, et al . Is transluminal coronary
angioplasty mandatory after successful thrombolysis : quantitative coro-
nary angiographic study . Br Heart J 1983 :50: 57-65 .
19
. O'Neill W, Timmis GC, Bourdillon PD, et al . A prospective randomized
clinical trial of intracoronary streptokinase versus coronary angioplasty
for acute myocardial infarction . N Engl J Med 1986 :314
:81 -8 .
0 . Simoons ML, Arnold AER, Betrin A, et al . Thrombolysis with tissue
plasminogen activator in acute myocardial infarction : no additional ben-
efit from immediate percutaneous coronary angioplasty
. Lancet 1988 :
1 :197- 03 .
1
. Sachs L
. Statistische Methoden . 5th ed . Berlin : Springer, 198 :14-5 .
. Kennedy JW. Ritchie JL, Davis KB, Stadius ML, Maynard C, Fritz JK
.
The Western Washington randomized trial of intracoronary streptokinase
in acute myocardial infarction . N Engl J Med 1985 :31 :1073-8 .
3 . ISAM Study Group
. A prospective trial of intravenous streptokinase in
acute myocardial infarction
. N Engl J Med 1986 ;314 :1465-71 .
4 . Satler LF . Green CE, McNamara NM. e
t al . Late angiography follow-up
after successful coronary arterial thrombolysis and angioplasty during
acute myocardial infarction . Am J Cardiol 1987
:60
:
10-3 .
5 . Chesebro JH, Knatterud G, Roberts R, et al . Thrombolysis in myocardial
infarction (TIMI) trial, Phase 1 : a comparison between intravenous tissue
plasminogen activator and intravenous streptokinase . Circulation 1987 :
76 :14 -54 .
6 . Guerci AD, Gerstenblith G, Brinker JA, et al
. A randomized trial of
intravenous tissue plasminogen activator for acute myocardial infarction
with subsequent randomization to elective coronary angioplasty . N Engl
J Med 1987
:317 :1613-8 .
7 . Simoons ML, Serruys PW, Van den Brand M, et al
. Early thrombolysis
in acute myocardial infarction
: limitation of infarct size and improved
survival . J Am Coll Cardiol 1986 :7 :717-
8 .
85
8 . Gruppo Italiano per to Studio della Streptochinasi nell'Infarto Myo-
cardico (GISSI) . Long term effects of intravenous thrombolysis in acute
myocardial infarction : final report of the GISSI study . Lancet 1987 ;
:871-4 .
9. Anderson JL, Marshall HW, Askins JC, et al . A randomized trial of
intravenous and intracoronary streptokinase in patients with acute myo-
cardial infarction . Circulation 1984;70 :606-18 .
30. Yusuf S, Collins R, Peto R, et al . Intravenous and intracoronary fibrin-
olytic therapy in acute myocardial infarction : overview of results on
mortality, reinfarction and side-effects from 33 randomized controlled
trials . Eur Heart J 1985 ;6 :556-85 .
31 . Rupprecht HJ, Brennecke R, Erbel R, et al . Early and long-term outcome
after PTCA in stable versus unstable angina (abstr) . J Am Coll Cardiol
1987 :9 :150A .
3 . Meyer J, Erbel R, Schmitz HJ, et al . Transluminale Angioplastik-
unstabile Angina . frischer Infarkt . Z Kardiol 1984 ;73 :167-76.
33 . Umans V, Heyndrickx, GR, van de Brand M, De Feyter PJ, Wijns W,
Jaski B . Elective PTCA of totally occluded coronary arteries not associ-
ated with acute myocardial infarction : short-term and long-term results .
Eur Heart J 1985 ;6 : -1 .
34 . Waller BF, Rothbaum DA, Pinkerton CA, et al . Status of the myocardium
and infarct-related coronary artery in 19 necropsy patients with acute
recanalization using pharmacologic (streptokinase, r-tissue plasminogen
activator), mechanical (percutaneous transluminal coronary angioplasty)
or combined types of reperfusion therapy . J Am Coll Cardiol 1987 :
9 :785-801 .
35
. Suryapranata H, Serruys PW . Vermeer F, et al . Value of immediate
coronary angioplasty following intracoronary thrombolysis in acute myo-
cardial infarction
. Cathet Cardiovasc Diagn 1987 ;13 : 3-3 .
36 . James TN, Bruschke AVG, Bothig S, et al
. Report of WHO/ISFC task
force on nomenclature of coronary arteriograms . Circulation 1986 ;
74 :451A-5A .
37
. Rosing DR, Cannon RO III, Watson RM, et al . Three year anatomic,
functional and clinical follow-up after successful percutaneous translum-
inal coronary angioplasty
. J Am Coll Cardiol 1987 :9 :1-7 .
38
. Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ .
Infarct artery perfusion and changes in left ventricular volume in the
month after acute myocardial infarction . J Am Coll Cardiol 1987 ;9 :
989-95 .
39 . O'Neill W
. Intracoronary streptokinase versus coronary angioplasty for
acute myocardial infarction
. N Engl J Med 1986 :315 :1094 .
40
. Olafsson B, Forman MB, Puett DW, et al . Reduction of reperfusion injury
in the canine preparation by intracoronary adenosine : importance of the
endothelium and the no-reflow phenomenon
. Circulation 1987 :76 :1135-
45 .
